Search for: "Pfizer Inc." Results 361 - 380 of 1,515
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Nov 2014, 7:09 am by Pete Strom
Pfizer Claims Zoloft Plaintiffs in MDL Cannot Prove Causation On Wednesday, November 5th, Pfizer Inc requested that a federal judge in Pennsylvania to dismiss more than 500 cases from the Zoloft injury multidistrict litigation (MDL) because, according to the pharmaceutical giant, the plaintiffs cannot prove that the antidepressant led to birth defects. [read post]
21 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- Anyone that has been monitoring the outcome of district court cases recently will be aware of the perils of not including sufficient information, or not timely supplementing, preliminary infringement or invalidity contentions required by many local patent rules. [read post]
21 Oct 2014, 9:03 am by Dennis Crouch
A number of Amici supported the petition, including BIO, Pfizer, Eli Lilly, PhRMA, IPO, and Merck. [read post]
19 Sep 2014, 9:29 pm by Patent Docs
Dianna DeVore of Oblon, Spivak, McClelland, Maier & Neustadt, LLP; Matthew Pugmire of Pfizer, Inc.; and Michael Samardzija of Dentons US LLP examine the alternative of using trade secrets to protect intellectual property in the life sciences. [read post]
18 Aug 2014, 9:52 am by David C. Scileppi
  His most recent experience was as Assistant General Counsel and Assistant Secretary with Pfizer. [read post]
12 Aug 2014, 1:21 pm
Plaintiffs recently filed at least 13 Zoloft injury lawsuits against Pfizer Inc. [read post]
2 Aug 2014, 6:05 am by Schachtman
Sinai Hospital and Medical Center of Chicago, Inc., 807 N.E.2d 1026, 1033 (Ill. [read post]
31 Jul 2014, 12:00 am
Rosenzweig During the past year, major corporations, including Chiquita Brands International Inc., Mallinckrodt Pharmaceuticals, Abbvie Inc., Applied Materials Inc., and Medtronic Inc., have announced or completed such deals. [read post]
23 Jul 2014, 3:33 pm by Bloomberg
Lawyers who battled Pfizer Inc. for more than a decade over women’s cancers linked to the company’s Prempro menopause drug settled a rare public dispute over $62 million in fees. [read post]
18 Jul 2014, 11:55 am
Pfizer, Inc., 716 F.3d 1087, 1092-93 (8th Cir. 2013). [read post]
15 Jul 2014, 5:27 am by Nietzer
Jay Martin, Chief Compliance Officer (CCO) at BakerHughes Inc. suggests an approach that reviews key risk factors to move forward. [read post]